Intera Oncology Inc. announced it raised $414,000 in an initial filing from an offering of $2.5 Million

Company

Location

About

Intera Oncology® Inc. is a privately held medical device company specializing in the development of the Intera 3000 Hepatic Artery Infusion Pump and floxuridine, an FDA-approved chemotherapy drug. The company focuses on providing solutions to treat liver-dominant metastases primarily caused by metastatic colorectal cancer through hepatic artery infusion therapy.